3 min.
Managing invasive fungal diseases is a dynamic expertise. In this interview, prof. Johan Maertens talks about the changing fungal landscape, both in terms of the host (i.e. haematological patients) as the type of fungal pathogen. Looking at these changes: what are the relevant challenges and therapeutic opportunities?
This editorially independent interview has been financially sponsored by Gilead.